Author

Z. Safikhani

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

B. Haibe-Kains· 2 shared D. M. A. Gendoo· 1 shared G. M. Chen· 1 shared G. Parmigiani· 1 shared L. Geistlinger· 1 shared L. Kannan· 1 shared L. Waldron· 1 shared M. Birrer· 1 shared

Activity by Year

2017-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. Haibe-Kains

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Karyotypic divergence confounds cellular phenotypes in large pharmacogenomic studies

R. Quevedo, N. El-Hachem, P. Smirnov, Z. Safikhani, T. J. Pugh, B. Haibe-Kains

This study identifies discordances in genotypic and karyotypic profiles across pharmacogenomic datasets, highlighting the impact of copy-number variants on drug response and the need for verification of cell line profiles.

bioRxiv · Mar 11, 2019 · PreprintCancer Biology

Consensus on Molecular Subtypes of Ovarian Cancer

G. M. Chen, L. Kannan, L. Geistlinger, V. Kofia, Z. Safikhani, D. M. A. Gendoo, G. Parmigiani, M. Birrer, B. Haibe-Kains, L. Waldron

The paper evaluates three ovarian cancer subtype classifiers, finds they are not robust, and proposes a consensus classifier with a 100-gene signature that improves stratification of a minority of tumors.

bioRxiv · Jul 12, 2017Cancer Biology